Toronto, Canada

Lei Sun

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: The Hospital for Sick Children, University of Toronto. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Sun. Retrieved from https://idiyas.com/inventor/lei-sun-kr7bx5uy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lei Sun - Pushing Boundaries of Technology Through Innovations

Introduction:

Lei Sun, a visionary inventor based in Toronto, CA, is known for his relentless pursuit of innovation and his passion for pushing the boundaries of technology. With a strong background in genetic research and a deep commitment to improving healthcare outcomes, Lei Sun has made significant contributions to the field of cystic fibrosis (CF) therapy.

Latest Patents:

Lei Sun's groundbreaking patent titled "Modifiers of CFTR-directed therapy" highlights his innovative approach towards predicting the efficacy of CFTR-directed therapy. By identifying genetic modifiers such as SNPs rs7512462 and rs2869027 in non-coding regions of SLC26A9, Lei Sun has paved the way for personalized treatment strategies for CF patients with specific mutations.

Career Highlights:

Having worked at The Hospital for Sick Children and The Governing Council of the University of Toronto, Lei Sun has established himself as a key figure in the research community. His dedication to improving the lives of CF patients through cutting-edge research has set him apart as a leader in the field of genetic medicine.

Collaborations:

Throughout his career, Lei Sun has collaborated with esteemed colleagues such as Johanna Rommens and Lisa Strug. Together, they have leveraged their expertise in genetics and molecular biology to drive forward innovative solutions for CF therapy. Their collaborative efforts have led to groundbreaking discoveries that have the potential to revolutionize treatment approaches for CF patients.

Conclusion:

Lei Sun's unwavering commitment to innovation and his ability to push the boundaries of technology make him a true visionary in the world of inventions. His groundbreaking research in the field of CF therapy not only showcases his technical expertise but also underscores his passion for making a meaningful impact in healthcare. As Lei Sun continues to spearhead cutting-edge research initiatives, his contributions are sure to shape the future of genetic medicine for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…